Nuclear phosphorylated STAT3 is known to regulate the DNMTs in hematopoietic cancer and colon cancer by binding to DNMT promoters to activate their expression [41,48]. This evidence concerns the gene STAT3 and hematopoietic and lymphoid cell neoplasm.